Optimal VAsopressor titraTION Pilot Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
HypotensionShock
Interventions
DRUG

Vasopressors

Trial Locations (10)

63141

Mercy Hospital, St Louis

Unknown

University of Alberta Hospital, Edmonton

Queens Elizabeth II Hospital, Halifax

The Ottawa Hospital, Ottawa

Sunnybrooke HSC, Toronto

Toronto General Hospital, Toronto

Hopital L'Enfant-Jesus, Québec

K7L 2V7

Kingston General Hospital, Kingston

M5G 1X5

Mt Sinai Hospital, Toronto

J1H 5N4

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Canadian Critical Care Trials Group

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Fonds de la Recherche en Santé du Québec

OTHER_GOV

lead

Francois Lamontagne

OTHER

NCT01800877 - Optimal VAsopressor titraTION Pilot Randomized Controlled Trial | Biotech Hunter | Biotech Hunter